Ridgeback Capital Investments as of Sept. 30, 2012
Portfolio Holdings for Ridgeback Capital Investments
Ridgeback Capital Investments holds 18 positions in its portfolio as reported in the September 2012 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Medicines Company | 15.8 | $27M | 1.1M | 25.81 | |
Ironwood Pharmaceuticals (IRWD) | 15.6 | $27M | 2.1M | 12.78 | |
Ariad Pharmaceuticals | 14.1 | $24M | 1.0M | 24.21 | |
Celldex Therapeutics | 10.5 | $18M | 2.9M | 6.30 | |
Gilead Sciences (GILD) | 9.7 | $17M | 250k | 66.33 | |
Santarus | 8.4 | $15M | 1.6M | 8.88 | |
Array BioPharma | 6.5 | $11M | 1.9M | 5.84 | |
Sunesis Pharmaceuticals | 5.4 | $9.2M | 1.6M | 5.63 | |
Clovis Oncology | 4.1 | $7.1M | 346k | 20.45 | |
Onyx Pharmaceuticals | 3.9 | $6.7M | 79k | 84.50 | |
Regeneron Pharmaceuticals (REGN) | 1.8 | $3.1M | 20k | 152.64 | |
Sangamo Biosciences (SGMO) | 1.3 | $2.3M | 376k | 6.08 | |
Dynavax Technologies Corporation | 1.0 | $1.7M | 353k | 4.76 | |
Hyperion Therapeutics | 0.7 | $1.2M | 115k | 10.63 | |
XenoPort | 0.6 | $1.1M | 95k | 11.45 | |
Biolinerx Ltd-spons | 0.3 | $498k | 190k | 2.63 | |
DUSA Pharmaceuticals | 0.2 | $388k | 57k | 6.78 | |
Lexicon Pharmaceuticals | 0.1 | $232k | 100k | 2.32 |